Mostrar el registro sencillo del ítem

Primary Care of Opioid use Disorder: The End of "the French Model"?

dc.rights.licenseopenen_US
dc.contributor.authorDUPOUY, J.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMAUMUS-ROBERT, Sandy
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMANSIAUX, Yohann
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorPARIENTE, Antoine
IDREF: 13395711X
dc.contributor.authorLAPEYRE-MESTRE, M.
dc.date.accessioned2021-01-22T11:10:37Z
dc.date.available2021-01-22T11:10:37Z
dc.date.issued2020
dc.identifier.issn1421-9891 (Electronic) 1022-6877 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/25960
dc.description.abstractEnBackground: In France, most patients with opioid use disorder (OUD) have been treated by buprenorphine, prescribed by general practitioners (GP) in private practice since 1996. This has contributed to building a ‘French model’ facilitating access to treatment based on the involvement of GPs in buprenorphine prescription. Objectives: Our study aimed to assess whether the involvement of primary care in OUD management has changed lately. Materials and Methods: Using data from the French National Health Insurance database, we conducted a yearly repeated cross-sectional study (2009–2015) and described proportion of opioid maintenance treatment (OMT)-prescribing GPs and OMT-dispensing community pharmacies (CP); and number of patients by GP or CP. Results: Whereas the number of buprenorphine-prescribing GPs in private practice remained quite stable (decrease of 3%), a substantial decrease in buprenorphine initial prescribers among private GPs was observed. In 2009, 10.3% of private GPs (6,297 from 61,301 French private GPs) prescribed buprenorphine for the initiation of a treatment, whereas they were 5.7% (n = 3,539 from 62,071 private GPs) in 2015 (43.8% decrease). GPs issuing initial prescriptions of buprenorphine tended to care for a higher number of patients treated by buprenorphine (14.6 ± 27.1 patients in 2009 to 16.0 ± 35.4 patients in 2015). The number of CPs dispensing buprenorphine remained quite stable (decrease of 2%), while there was a 7.5% decrease in the total number of French CPs across the study period. Conclusions: Our results suggest that primary care providers seem less engaged in buprenorphine initiation in OUD patients, while CPs have not modified their involvement towards these patients.
dc.language.isoENen_US
dc.subjectPharmacoEpi-Drugs
dc.title.enPrimary Care of Opioid use Disorder: The End of "the French Model"?
dc.title.alternativeEur Addict Resen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1159/000506630en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed32155620en_US
bordeaux.journalEuropean Addiction Researchen_US
bordeaux.page346-354en_US
bordeaux.volume26en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue6en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03118522
hal.version1
hal.date.transferred2021-01-22T11:10:41Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=European%20Addiction%20Research&rft.date=2020&rft.volume=26&rft.issue=6&rft.spage=346-354&rft.epage=346-354&rft.eissn=1421-9891%20(Electronic)%201022-6877%20(Linking)&rft.issn=1421-9891%20(Electronic)%201022-6877%20(Linking)&rft.au=DUPOUY,%20J.&MAUMUS-ROBERT,%20Sandy&MANSIAUX,%20Yohann&PARIENTE,%20Antoine&LAPEYRE-MESTRE,%20M.&rft.genre=article


Archivos en el ítem

ArchivosTamañoFormatoVer

No hay archivos asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem